RealFeedApp Drug companies test medications on specific patient groups
A bipartisan group of lawmakers urges the FDA to close a regulatory gap allowing peptides to be marketed as drugs without full clinical trials.
- Field
- medicine and diagnostics
- What they did
- FDA officials are discussing a policy that requires drugs to be tested on their intended patient population.
- Why it matters
- This is necessary to ensure the safety and effectiveness of drugs before they are approved for use.
#fda#regulation#peptides#clinical trials#policy
